The Manchester Genomic Medicine Centre is the largest in the UK and consists of over 150 employees with 20 consultants in Genomic Medicine and 25 Genetic counsellors.
Strong track record on genomic diagnosis. Developed NGS platforms for somatic testing of many different primary cancers as well as on neurofibromatosis. Manchester is the lead centre for trhe 4 centre highly specialised NF2 service as well as being the partner centre of two for the highly specialised complex NF1 service. Manchester is the national testing centre for all forms of neurofibromatosis in England (NF1, NF2, SMARCB1, LZTR1). Prof Evans Manchester PI has a strong track record in leading and recruiting to clinical trials.